SCUDERI, SIMONE LUCA ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 147
EU - Europa 126
AS - Asia 47
SA - Sud America 1
Totale 321
Nazione #
US - Stati Uniti d'America 145
SE - Svezia 63
IT - Italia 26
CN - Cina 25
RU - Federazione Russa 16
SG - Singapore 16
DE - Germania 5
FI - Finlandia 5
IN - India 4
BE - Belgio 2
CA - Canada 2
CZ - Repubblica Ceca 2
IE - Irlanda 2
GB - Regno Unito 1
GR - Grecia 1
HK - Hong Kong 1
MK - Macedonia 1
PL - Polonia 1
PY - Paraguay 1
SA - Arabia Saudita 1
UA - Ucraina 1
Totale 321
Città #
New York 34
Ashburn 20
Shanghai 16
Boardman 12
Lawrence 12
Princeton 12
Milan 11
Singapore 10
Moscow 9
Helsinki 5
Pune 4
Rome 4
Paderborn 3
Bethesda 2
Brussels 2
Dublin 2
Los Angeles 2
Palermo 2
Québec 2
Asunción 1
Athens 1
Borås 1
Council Bluffs 1
Crotone 1
Freiburg im Breisgau 1
Gaithersburg 1
Genoa 1
Giussano 1
Jeddah 1
London 1
Nov Dojran 1
Padova 1
Seattle 1
Segrate 1
Sesto San Giovanni 1
Totale 180
Nome #
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 34
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 26
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 25
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 23
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer 23
Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy 21
Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions 21
Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series 21
Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy 18
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 17
Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial 17
Diagnostic and prognostic factors in patients with prostate cancer: A systematic review protocol 17
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 17
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 17
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 16
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 14
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database 13
Totale 340
Categoria #
all - tutte 3.769
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.769


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 1 0 0 0 0 0 0 0
2020/20213 0 0 0 0 0 2 0 0 1 0 0 0
2021/202223 0 7 1 9 0 0 1 2 0 0 0 3
2022/2023110 30 23 9 8 3 12 3 15 0 0 2 5
2023/2024172 4 12 19 13 16 43 0 24 0 12 10 19
2024/202531 31 0 0 0 0 0 0 0 0 0 0 0
Totale 340